A retrospective study of the treatment outcome of drug therapies used in heart failure patients with associated co-morbidities in a tertiary care hospital

Harish Thanusubramanian, K. Meena Kumari, Ranjan Shetty, Amberkar Mohan Babu Vittalrao

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

© 2016, Journal of Clinical and Diagnostic Research. All rights reserved. Introduction: Heart failure is one of the most common heart problems seen in the Indian population. There are various drugs used to prevent further progression of the disease. In India, there are few studies in relation to treatment outcome in a tertiary care hospital. Aim: To study the treatment outcome of drug therapies used in heart failure patients with associated co-morbidities in a tertiary care hospital. Materials and Methods: This was an observational study conducted on 250 patients with heart failure. Details collected using the proforma were demography (age, gender); medical history; medication history for heart failure patients on admission and discharge; ejection fraction; median length of stay in hospital; number of readmissions & in-hospital mortality. Results: One hundred and twenty eight patients categorized into LVSD group (ejection fraction <40%) and 122 patients in PSF group (ejection fraction > 40%). Medical history of coronary artery disease (54%) was significantly higher in LVSD group (p <0.05) and anaemia (19%) was significantly higher in PSF group (p <0.05). On admission, inotropes (30%), digoxin (59%) and statins (54%) were prescribed more in LVSD patients (p <0.05) while calcium channel blockers (20%) were prescribed more in PSF group (p <0.05). At discharge, patients with LVSD were receiving ACE inhibitors (51%), beta blockers (30%), digoxin (67%) and statins (59%) (p <0.05) while calcium channel blockers (20%) was prescribed more in PSF group. The median length of stay was slightly higher in patients with PSF (7 days) as compared to LVSD (6 days). In-hospital mortality was lower in patients with PSF (6%) than patients with LVSD (20%). The percentage of readmissions within one month was slightly higher in patients with PSF (15%) compared to LVSD (14%). Conclusion: Length of stay in hospital was 6-7 days in heart failure patients. In hospital mortality in LVSD patients (20%) was higher compared to PSF patients (6%). A 15% heart failure patient were readmitted within 1month of discharge.
Original languageEnglish
Pages (from-to)FC06-FC09
JournalJournal of Clinical and Diagnostic Research
Volume10
Issue number6
DOIs
Publication statusPublished - 01-06-2016

Fingerprint

Drug therapy
Tertiary Healthcare
Tertiary Care Centers
Heart Failure
Retrospective Studies
Morbidity
Drug Therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Digoxin
Calcium Channel Blockers
Hospital Mortality
Length of Stay
Angiotensin-Converting Enzyme Inhibitors
Patient Discharge
Patient Admission
Observational Studies
Pharmaceutical Preparations
Disease Progression
Anemia
Coronary Artery Disease

Cite this

@article{807441e76e544ec4991f951c52c606fc,
title = "A retrospective study of the treatment outcome of drug therapies used in heart failure patients with associated co-morbidities in a tertiary care hospital",
abstract = "{\circledC} 2016, Journal of Clinical and Diagnostic Research. All rights reserved. Introduction: Heart failure is one of the most common heart problems seen in the Indian population. There are various drugs used to prevent further progression of the disease. In India, there are few studies in relation to treatment outcome in a tertiary care hospital. Aim: To study the treatment outcome of drug therapies used in heart failure patients with associated co-morbidities in a tertiary care hospital. Materials and Methods: This was an observational study conducted on 250 patients with heart failure. Details collected using the proforma were demography (age, gender); medical history; medication history for heart failure patients on admission and discharge; ejection fraction; median length of stay in hospital; number of readmissions & in-hospital mortality. Results: One hundred and twenty eight patients categorized into LVSD group (ejection fraction <40{\%}) and 122 patients in PSF group (ejection fraction > 40{\%}). Medical history of coronary artery disease (54{\%}) was significantly higher in LVSD group (p <0.05) and anaemia (19{\%}) was significantly higher in PSF group (p <0.05). On admission, inotropes (30{\%}), digoxin (59{\%}) and statins (54{\%}) were prescribed more in LVSD patients (p <0.05) while calcium channel blockers (20{\%}) were prescribed more in PSF group (p <0.05). At discharge, patients with LVSD were receiving ACE inhibitors (51{\%}), beta blockers (30{\%}), digoxin (67{\%}) and statins (59{\%}) (p <0.05) while calcium channel blockers (20{\%}) was prescribed more in PSF group. The median length of stay was slightly higher in patients with PSF (7 days) as compared to LVSD (6 days). In-hospital mortality was lower in patients with PSF (6{\%}) than patients with LVSD (20{\%}). The percentage of readmissions within one month was slightly higher in patients with PSF (15{\%}) compared to LVSD (14{\%}). Conclusion: Length of stay in hospital was 6-7 days in heart failure patients. In hospital mortality in LVSD patients (20{\%}) was higher compared to PSF patients (6{\%}). A 15{\%} heart failure patient were readmitted within 1month of discharge.",
author = "Harish Thanusubramanian and {Meena Kumari}, K. and Ranjan Shetty and Vittalrao, {Amberkar Mohan Babu}",
year = "2016",
month = "6",
day = "1",
doi = "10.7860/JCDR/2016/18636.7989",
language = "English",
volume = "10",
pages = "FC06--FC09",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "6",

}

TY - JOUR

T1 - A retrospective study of the treatment outcome of drug therapies used in heart failure patients with associated co-morbidities in a tertiary care hospital

AU - Thanusubramanian, Harish

AU - Meena Kumari, K.

AU - Shetty, Ranjan

AU - Vittalrao, Amberkar Mohan Babu

PY - 2016/6/1

Y1 - 2016/6/1

N2 - © 2016, Journal of Clinical and Diagnostic Research. All rights reserved. Introduction: Heart failure is one of the most common heart problems seen in the Indian population. There are various drugs used to prevent further progression of the disease. In India, there are few studies in relation to treatment outcome in a tertiary care hospital. Aim: To study the treatment outcome of drug therapies used in heart failure patients with associated co-morbidities in a tertiary care hospital. Materials and Methods: This was an observational study conducted on 250 patients with heart failure. Details collected using the proforma were demography (age, gender); medical history; medication history for heart failure patients on admission and discharge; ejection fraction; median length of stay in hospital; number of readmissions & in-hospital mortality. Results: One hundred and twenty eight patients categorized into LVSD group (ejection fraction <40%) and 122 patients in PSF group (ejection fraction > 40%). Medical history of coronary artery disease (54%) was significantly higher in LVSD group (p <0.05) and anaemia (19%) was significantly higher in PSF group (p <0.05). On admission, inotropes (30%), digoxin (59%) and statins (54%) were prescribed more in LVSD patients (p <0.05) while calcium channel blockers (20%) were prescribed more in PSF group (p <0.05). At discharge, patients with LVSD were receiving ACE inhibitors (51%), beta blockers (30%), digoxin (67%) and statins (59%) (p <0.05) while calcium channel blockers (20%) was prescribed more in PSF group. The median length of stay was slightly higher in patients with PSF (7 days) as compared to LVSD (6 days). In-hospital mortality was lower in patients with PSF (6%) than patients with LVSD (20%). The percentage of readmissions within one month was slightly higher in patients with PSF (15%) compared to LVSD (14%). Conclusion: Length of stay in hospital was 6-7 days in heart failure patients. In hospital mortality in LVSD patients (20%) was higher compared to PSF patients (6%). A 15% heart failure patient were readmitted within 1month of discharge.

AB - © 2016, Journal of Clinical and Diagnostic Research. All rights reserved. Introduction: Heart failure is one of the most common heart problems seen in the Indian population. There are various drugs used to prevent further progression of the disease. In India, there are few studies in relation to treatment outcome in a tertiary care hospital. Aim: To study the treatment outcome of drug therapies used in heart failure patients with associated co-morbidities in a tertiary care hospital. Materials and Methods: This was an observational study conducted on 250 patients with heart failure. Details collected using the proforma were demography (age, gender); medical history; medication history for heart failure patients on admission and discharge; ejection fraction; median length of stay in hospital; number of readmissions & in-hospital mortality. Results: One hundred and twenty eight patients categorized into LVSD group (ejection fraction <40%) and 122 patients in PSF group (ejection fraction > 40%). Medical history of coronary artery disease (54%) was significantly higher in LVSD group (p <0.05) and anaemia (19%) was significantly higher in PSF group (p <0.05). On admission, inotropes (30%), digoxin (59%) and statins (54%) were prescribed more in LVSD patients (p <0.05) while calcium channel blockers (20%) were prescribed more in PSF group (p <0.05). At discharge, patients with LVSD were receiving ACE inhibitors (51%), beta blockers (30%), digoxin (67%) and statins (59%) (p <0.05) while calcium channel blockers (20%) was prescribed more in PSF group. The median length of stay was slightly higher in patients with PSF (7 days) as compared to LVSD (6 days). In-hospital mortality was lower in patients with PSF (6%) than patients with LVSD (20%). The percentage of readmissions within one month was slightly higher in patients with PSF (15%) compared to LVSD (14%). Conclusion: Length of stay in hospital was 6-7 days in heart failure patients. In hospital mortality in LVSD patients (20%) was higher compared to PSF patients (6%). A 15% heart failure patient were readmitted within 1month of discharge.

UR - http://www.scopus.com/inward/record.url?scp=84973345193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973345193&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2016/18636.7989

DO - 10.7860/JCDR/2016/18636.7989

M3 - Article

VL - 10

SP - FC06-FC09

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 6

ER -